The Research Team at Minerva Biotechnologies focuses on the discovery and development of innovative cancer immunotherapies and drugs. Comprising a diverse group of scientists, the team conducts cutting-edge research to identify novel targets for solid tumors and explores strategies to prevent cancer metastasis, ultimately aiming to enhance patient outcomes and advance cancer treatment options.